Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: jef saunders who wrote (7617)	8/17/2001 4:18:12 PM
From: jef saunders	Read Replies (2) \| Respond to of 14101

WE SOLD OUR FIRST MILLION DOLLARS OF PENNSAID !!!!! AND IT TOOK LESS THAN 2 MONTHS !! WOW. there. i wanted to add some enthusiasm and celebreation to that last post. i just listened to the conference call and it's EXCITING (to me at least). OVER c$700,000 pennsaid sales in ONE MONTH !! and that was before the national institute center for excellence (there) said no vioxx nor celebrex (for low asprin users, patients with cardiovascular risk (most old people) , or as a front line choice.). provalis will be using all that heartily, rebecca's happy with their efforts. my raddy notes. end of 2nd quarter (november). oxo-chemie trial results by end of november , 13 countries paperwork november. canada hopefully by november. nasdaq this fiscal year so by may 31st , 2002. europe this fiscal year. lots of fda talk in the q and a: 2 houses questions: fda very cooperative, helpful since day 1. very good working relationship mfg has been big fda holdup, delay. parke davis was mfg., then sold the plant. fda inspection is only thing left, by at least end of november. fda will respond after that. plant has european union approval for ALL drugs it might make. jeffS